JP2022544581A5 - - Google Patents
Info
- Publication number
- JP2022544581A5 JP2022544581A5 JP2022509577A JP2022509577A JP2022544581A5 JP 2022544581 A5 JP2022544581 A5 JP 2022544581A5 JP 2022509577 A JP2022509577 A JP 2022509577A JP 2022509577 A JP2022509577 A JP 2022509577A JP 2022544581 A5 JP2022544581 A5 JP 2022544581A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- domain
- pharmaceutical composition
- composition according
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962888055P | 2019-08-16 | 2019-08-16 | |
| US62/888,055 | 2019-08-16 | ||
| PCT/US2020/046439 WO2021034689A1 (en) | 2019-08-16 | 2020-08-14 | Anti-cd83 chimeric antigen receptor expressing t regulatory cells |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022544581A JP2022544581A (ja) | 2022-10-19 |
| JP2022544581A5 true JP2022544581A5 (enExample) | 2023-08-18 |
| JP7701908B2 JP7701908B2 (ja) | 2025-07-02 |
Family
ID=74660009
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022509577A Active JP7701908B2 (ja) | 2019-08-16 | 2020-08-14 | 抗ｃｄ３８キメラ抗原受容体を発現する制御性ｔ細胞 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220289862A1 (enExample) |
| EP (1) | EP4013447A4 (enExample) |
| JP (1) | JP7701908B2 (enExample) |
| CN (1) | CN114615992A (enExample) |
| AU (1) | AU2020333659A1 (enExample) |
| CA (1) | CA3147837A1 (enExample) |
| WO (1) | WO2021034689A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12492254B2 (en) | 2018-02-23 | 2025-12-09 | H. Lee Moffitt Cancer Center and Research Intitute. Inc. | CD83-binding chimeric antigen receptors |
| CA3147835A1 (en) * | 2019-08-16 | 2021-02-25 | H. Lee Moffitt Cancer Center And Research Institute Inc. | Chimeric antigen receptors for treating myeloid malignancies |
| WO2022260909A1 (en) * | 2021-06-09 | 2022-12-15 | H. Lee Moffitt Cancer Center And Research Institute Inc. | Methods of using anti-cd83 chimeric antigen receptor expressing t cells |
| US20250052748A1 (en) * | 2021-12-22 | 2025-02-13 | Regents Of The University Of Minnesota | Cd83 and allo- and autoimmune conditions |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040185040A1 (en) * | 2001-11-21 | 2004-09-23 | Celltech R & D Limited | Modulating immune responses |
| WO2009155477A1 (en) * | 2008-06-19 | 2009-12-23 | The Trustees Of The University Of Pennsylvania | Inducible regulatory t-cell generation for hematopoietic transplants |
| JP2013150592A (ja) * | 2011-07-01 | 2013-08-08 | Genentech Inc | 自己免疫疾患を治療するための抗ｃｄ８３アゴニスト抗体の使用 |
| JP2013040160A (ja) * | 2011-07-01 | 2013-02-28 | Genentech Inc | 自己免疫疾患を治療するための抗ｃｄ８３アゴニスト抗体の使用 |
| AU2014213009B2 (en) * | 2013-02-01 | 2019-01-03 | Kira Biotech Pty Limited | Anti-CD83 antibodies and use thereof |
| AU2016274989A1 (en) * | 2015-06-12 | 2017-11-02 | Immunomedics, Inc. | Disease therapy with chimeric antigen receptor (car) constructs and t cells (car-t) or nk cells (car-nk) expressing car constructs |
| JP6974311B2 (ja) * | 2015-06-23 | 2021-12-01 | メモリアル スローン ケタリング キャンサー センター | 新規ｐｄ−１免疫調節剤 |
| SG11201807489PA (en) * | 2016-03-04 | 2018-09-27 | Novartis Ag | Cells expressing multiple chimeric antigen receptor (car) molecules and uses therefore |
| US11814432B2 (en) * | 2017-09-20 | 2023-11-14 | The University Of British Columbia | Anti-HLA-A2 antibodies, related chimeric antigen receptors, and uses thereof |
| WO2019136335A1 (en) * | 2018-01-05 | 2019-07-11 | Gencyte Therapeutics, Inc. | Precision molecular adaptor system for car-t immunotherapy |
| CN111684061B (zh) * | 2018-01-19 | 2024-07-30 | 美天施生物科技有限两合公司 | 表达嵌合抗原受体的调节性t细胞 |
| ES3012854T3 (en) * | 2018-02-08 | 2025-04-10 | Univ Leland Stanford Junior | Allogenic hematopoietic stem cell transplantation |
| US12492254B2 (en) * | 2018-02-23 | 2025-12-09 | H. Lee Moffitt Cancer Center and Research Intitute. Inc. | CD83-binding chimeric antigen receptors |
-
2020
- 2020-08-14 EP EP20854296.9A patent/EP4013447A4/en active Pending
- 2020-08-14 WO PCT/US2020/046439 patent/WO2021034689A1/en not_active Ceased
- 2020-08-14 CN CN202080063859.0A patent/CN114615992A/zh active Pending
- 2020-08-14 JP JP2022509577A patent/JP7701908B2/ja active Active
- 2020-08-14 AU AU2020333659A patent/AU2020333659A1/en active Pending
- 2020-08-14 CA CA3147837A patent/CA3147837A1/en active Pending
- 2020-08-14 US US17/635,119 patent/US20220289862A1/en active Pending